ObjectiveTo investigate the clinical characteristics, safety and clinical value of therapeutic endoscopic retrograde cholangiopancreatography(ERCP) in super elderly patients with cholangiopancreatosis aged 80 years or above.

MethodsThe clinical data of 387 patients treated with ERCP diagnosis and treatment were retrospectively analyzed.According to the patients' ages, the patients were divided into the elderly group(≥ 80 years) and non-elderly group(< 80 years), and the clinical characteristics and complications in two groups were analyzed.

ResultsThere were 193 patients in the elderly group, and the average age of which was (84.20±3.40) years old.There were 194 patients in the non-elderly group, and the average age of which was (60.10±13.52) years old.The proportion of elderly patients complicated with hypertension, diabetes, coronary atherosclerotic heart disease, cerebrovascular disease, duodenal parapillary diverticulum, malignant obstructive jaundice and stent implantation or replacement in the surgical method in elderly group were higher than those in non-elderly group(P < 0.05 to P < 0.01).Among the super elderly pateints, the primary disease for malignant obstructive jaundice rate, and complicated with hypertension, coronary atherosclerotic heart disease, and duodenal parapillary diverticulum rates in patients with postoperative bleeding were higher tahn those in patients without postoperative bleeding(P < 0.05 to P < 0.01).

ConclusionsSuper elderly patients with cholangiopancreatosis have many complications, but ERCP is still safe and effective, and can be used as the first choice for clinical treatment.